Evidence map›Paper›PMID 25179749›Full record

ArticleBMC cardiovascular disorders2014

Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation.

Tobias Kammerer, Andres Beiras-Fernandez, Markus Rehm, Manfred Stangl, Markus Guba, Christian Kupatt-Jeremias, Florian Weis

Abstract readCase Reports
In one paragraph

Article in BMC cardiovascular disorders, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tobias Kammerer
Andres Beiras-FernandezDepartment of Thoracic and Cardiovascular Surgery, University Hospital, JW Goethe-University, Theodor-Stern-Kai 7, 61590 Frankfurt, Germany. andres.beiras@kgu.de.
Markus Rehm
Manfred Stangl
Markus Guba
Christian Kupatt-Jeremias
Florian Weis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor's pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary artery disease is a growing problem. An increasing number of patients, undergoing living donation, receive antiplatelet therapies due to coronary disease. CASE PRESENTATION: Here we report about the perioperative treatment with a drug-eluting balloon in a patient with major cardiac risk factors who underwent kidney transplantation.

conclusionAt the current time no recommendation can be given for the routine use of drug-eluting balloons.

Indexed as

Drug-Eluting StentsLiving DonorsAgedAngioplasty, Balloon, CoronaryAnticoagulantsCoronary AngiographyCoronary Artery DiseaseCoronary RestenosisCoronary ThrombosisDiabetic NephropathiesHumansKidney TransplantationMalePatient Care TeamPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsAnticoagulantsPlatelet Aggregation Inhibitors

Identifiers

PMID25179749
PMCPMC4162970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.